Useful: External sites
Ministry of Health, Labour and Welfare
Drug-resistant bacteria are increasing globally due to inappropriate use of antimicrobials, while the development of new antimicrobials is declining, posing a major challenge to the international community.
In May 2015, the World Health Assembly adopted a Global Action Plan on Drug Resistance (AMR), and member countries have two years to Member countries were asked to develop national action plans on drug resistance within two years.
In response, the Ministry of Health, Labour and Welfare (MHLW) discussed comprehensive measures to combat drug resistance, and established the "Coordination Meeting on Drug Resistance (open in a new window)" under the "Ministerial Conference on Countermeasures to Combat Internationally Threatening Infectious Diseases," and held discussions and coordination with related ministries. On April 5, 2016, the Cabinet Meeting decided on Japan's first Action Plan.
Based on the Action Plan, we will promote effective measures in cooperation with related ministries and agencies, including a public campaign to ensure that "appropriate drugs" are used "only when necessary" and in "appropriate quantities and for appropriate periods of time.
AMR Clinical Reference Center
The development of antimicrobial agents and the acquisition of bacterial resistance are a game. No matter how many new antimicrobial agents are developed by mankind, bacteria become resistant to new agents one after another.
Finally, in 1993, the nightmare bacterium Carbapenem-resistant Enterobacteriaceae (CRE) was discovered, which is resistant to carbapenems, which had been the ultimate weapon against resistant bacteria.
CRE includes bacteria that are resistant to every antimicrobial drug in existence. When infected with these bacteria, there is no longer any way to treat the infection with antimicrobials. CRE is still spreading around the world and is one of the reasons for the global call for AMR control. We need to take infection control measures and use antimicrobials appropriately to prevent the spread of these organisms as much as possible.
World Health Organization (WHO)
One of the five AMR control objectives adopted by WHO in 2015 is "to develop a sustainable economic case for sustainable investment that takes into account the needs of all countries and to increase investment in new drugs, diagnostic tools, vaccines and other interventions. to develop the economic case for sustainable investment that takes account of the needs of all countries and to increase investment in new medicines, diagnostic tools, vaccines and other The following is an introduction to the efforts of various countries and organizations to develop the economic case for sustainable investment that takes account of the needs of all countries and to increase investment in new medicines, diagnostic tools, vaccines and other interventions.
Centers for Disease Control and Prevention (CDC)
The Centers for Disease Control and Prevention (CDC) is the federal agency responsible for leading the protection of human health and safety at home and abroad. The CDC is charged with promoting health through strong partnerships and providing reliable information on which to base health decisions.
The Japan Association for the Appropriate Use of Drugs (RAD-AR)
The Council for the Appropriate Use of Drugs blog has a new article titled "Antibiotics No Longer Effective? -Drug Resistance (AMR)," along with a video from the AMR Reference Center, "STOP AMR! Drug Resistance" is posted on the blog.
Antibiotics no longer effective? Drug Resistance (AMR)